Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Human immunodeficiency virus (HIV) point-of-care (POC) testing vs. laboratory-based testing (maternal/birth/6 months)

Domaine:

healthcare

Type de record:

dataset
Créateur:
Mic
Éditeur:
University of Pretoria
Hôte:avatar
Data relating to infants exposed to HIV born between 2018 and 2019 who received a birth HIV PCR POC test at a Provincial Tertiary Hospital in South Africa. They were compared with a historical control born between 2014 and 2016 who received only laboratory-based HIV PCR testing. Additional data included data relating to their mothers and the infants' six-month outcomes (mortality, retention in care and HIV viral load suppression) .

Visit

doi.org

Tags

Infectious diseases

Licenses

Creative Commons Attribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/legalcode

Similaires

Point-of-Care TestingPoint-of-Care Tenofovir Urine Testing for the Prediction of Treatment Failure and Drug Resistance During Initial Treatment for Human Immunodeficiency Virus Type 1 (HIV-1) InfectionA Randomized Trial of Point-of-Care Early Infant Human Immunodeficiency Virus (HIV) Diagnosis in Zambia Microfluidic-based Point-of-Care Testing for Global HealthUtilization of Human Immunodeficiency Virus (HIV) Testing Services Among Undergraduate Students In Usmanu Danfodiyo University, Sokoto, NigeriaPoint-of-Care Testing to Guide Treatment and Estimate Risk Factors for Sexually Transmitted Infections in Adolescents and Young People With Human Immunodeficiency Virus in Eswatini

Point-of-Care Testing

⚠️ Synthetic dataset — Parameterized from published SSA literature, not real observations. Not suita

Point-of-Care Tenofovir Urine Testing for the Prediction of Treatment Failure and Drug Resistance During Initial Treatment for Human Immunodeficiency Virus Type 1 (HIV-1) Infection

ABSTRACT Background Viral rebound during antiretroviral treatment (ART) is most often driven by s

A Randomized Trial of Point-of-Care Early Infant Human Immunodeficiency Virus (HIV) Diagnosis in Zambia

Abstract Background Point-of-care (POC) ear

Microfluidic-based Point-of-Care Testing for Global Health

Point-of-care (POC) tests can improve the management of infectious diseases and clinical outcomes, t

Utilization of Human Immunodeficiency Virus (HIV) Testing Services Among Undergraduate Students In Usmanu Danfodiyo University, Sokoto, Nigeria

Background: The Human Immunodeficiency Virus (HIV) continues to pose significant public health chall

Point-of-Care Testing to Guide Treatment and Estimate Risk Factors for Sexually Transmitted Infections in Adolescents and Young People With Human Immunodeficiency Virus in Eswatini

Abstract Background The World Health Organi